Dolby Laboratories Beheer

Beheer criteriumcontroles 3/4

De CEO Dolby Laboratories is Kevin Yeaman, benoemd in Mar2009, heeft een ambtstermijn van 15.67 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 9.50M, bestaande uit 9.8% salaris en 90.2% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.088% van de aandelen van het bedrijf, ter waarde € 6.48M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 8.1 jaar en 11.8 jaar.

Belangrijke informatie

Kevin Yeaman

Algemeen directeur

US$9.5m

Totale compensatie

Percentage CEO-salaris	9.8%
Dienstverband CEO	15.7yrs
Eigendom CEO	0.09%
Management gemiddelde ambtstermijn	8.1yrs
Gemiddelde ambtstermijn bestuur	11.8yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Kevin Yeaman's beloning veranderd ten opzichte van Dolby Laboratories's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 27 2024	n/a	n/a	US$262m
Jun 28 2024	n/a	n/a	US$212m
Mar 29 2024	n/a	n/a	US$190m
Dec 29 2023	n/a	n/a	US$188m
Sep 29 2023	US$10m	US$929k	US$201m
Jun 30 2023	n/a	n/a	US$219m
Mar 31 2023	n/a	n/a	US$242m
Dec 30 2022	n/a	n/a	US$183m
Sep 30 2022	US$9m	US$919k	US$184m
Jul 01 2022	n/a	n/a	US$201m
Apr 01 2022	n/a	n/a	US$216m
Dec 31 2021	n/a	n/a	US$255m
Sep 24 2021	US$10m	US$872k	US$310m
Jun 25 2021	n/a	n/a	US$293m
Mar 26 2021	n/a	n/a	US$306m
Dec 25 2020	n/a	n/a	US$318m
Sep 25 2020	US$8m	US$847k	US$231m
Jun 26 2020	n/a	n/a	US$248m
Mar 27 2020	n/a	n/a	US$221m
Dec 27 2019	n/a	n/a	US$206m
Sep 27 2019	US$7m	US$818k	US$255m
Jun 28 2019	n/a	n/a	US$238m
Mar 29 2019	n/a	n/a	US$201m
Dec 28 2018	n/a	n/a	US$193m
Sep 28 2018	US$8m	US$783k	US$42m

Compensatie versus markt: De totale vergoeding ($USD 9.50M ) Kevin } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de German markt ($USD 3.59M ).

Compensatie versus inkomsten: De vergoeding van Kevin is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Kevin Yeaman (58 yo)

15.7yrs

Tenure

US$9,504,201

Compensatie

Mr. Kevin J. Yeaman has been the Chief Executive Officer and President of Dolby Laboratories, Inc. since March 28, 2009 and serves as its Director since March 28, 2009. Mr. Yeaman served as the Chief Finan...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kevin Yeaman	President	15.7yrs	US$9.50m	0.088% € 6.5m
Robert Park	Senior VP & CFO	3.1yrs	US$3.29m	0.019% € 1.4m
Andy Sherman	Executive VP	13.8yrs	US$3.51m	0.018% € 1.3m
Todd Pendleton	Senior VP & Chief Marketing Officer	6.3yrs	US$3.19m	geen gegevens
John Couling	Senior Vice President of Entertainment	8.1yrs	US$3.90m	0.067% € 4.9m
Ryan Nicholson	VP, Corporate Controller & Chief Accounting Officer	9.3yrs	geen gegevens	0.010% € 735.3k
Craig Todd	CTO & Senior VP	no data	geen gegevens	geen gegevens
Edwin Marin	Senior VP & Chief Information Officer	no data	geen gegevens	geen gegevens
Peter Goldmacher	Vice President of Investor Relations	no data	geen gegevens	geen gegevens
Linda Rogers	Senior VP & Chief People Officer	7.8yrs	geen gegevens	geen gegevens
Ioan Allen	Senior Vice President	no data	geen gegevens	geen gegevens
Giles Baker	Senior Vice President of Cloud Media Solutions	8.1yrs	US$3.36m	geen gegevens

8.1yrs

Gemiddelde duur

52.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van FUO is doorgewinterd en ervaren (gemiddelde ambtstermijn van 8.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kevin Yeaman	President	15.7yrs	US$9.50m	0.088% € 6.5m
Peter Gotcher	Independent Chairman	21.4yrs	US$415.48k	0.043% € 3.1m
Avadis Tevanian	Independent Director	15.8yrs	US$367.48k	0.059% € 4.4m
Simon Segars	Independent Director	9.8yrs	US$345.48k	0.039% € 2.9m
Tony Prophet	Independent Director	2.9yrs	US$338.94k	0.0066% € 488.7k
Anjali Sud	Independent Director	5.5yrs	US$335.48k	0.0064% € 470.2k
David Dolby	Director	13.8yrs	US$330.48k	0.087% € 6.4m
Emily Rollins	Independent Director	3.8yrs	US$355.48k	0.0048% € 351.4k

11.8yrs

Gemiddelde duur

58yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van FUO zijn ervaren en ervaren (gemiddelde ambtstermijn van 11.8 jaar).

Dolby Laboratories Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Senior VP & Chief Marketing Officer recently sold €933k worth of stock

Insufficient new directors

Dolby Laboratories, Inc. Announces Committee Changes

Dolby Laboratories, Inc., Annual General Meeting, Feb 06, 2024

Senior VP & Chief Marketing Officer recently sold €799k worth of stock

Independent Director recently sold €198k worth of stock

Recent updates

Dolby Laboratories, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2025

Dolby Laboratories, Inc. to Report Q4, 2024 Results on Nov 19, 2024

Dolby Unveils New, Live Streaming Offering for the Sport and Entertainment Industries At IBC 2024

Third quarter dividend of US$0.30 announced

Third quarter 2024 earnings released: EPS: US$0.40 (vs US$0.17 in 3Q 2023)

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on August 27, 2024

Now 22% undervalued after recent price drop

Dolby Laboratories, Inc. (NYSE:DLB) acquired THEOplayer.

Dolby Laboratories, Inc. to Report Q3, 2024 Results on Aug 07, 2024

Dolby Laboratories, Inc. (NYSE:DLB) entered into a definitive agreement to acquire Ge Trademark Licensing, Inc. from General Electric Company (NYSE:GE) for approximately $430 million.

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings released: EPS: US$1.02 (vs US$1.00 in 2Q 2023)

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on May 22, 2024

Dolby Laboratories, Inc. to Report Q2, 2024 Results on May 02, 2024

Senior VP & Chief Marketing Officer recently sold €933k worth of stock

Insufficient new directors

Dolby Laboratories, Inc. Announces Committee Changes

First quarter dividend of US$0.30 announced

First quarter 2024 earnings released: EPS: US$0.70 (vs US$0.83 in 1Q 2023)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Dolby Laboratories, Inc. to Report Q1, 2024 Results on Feb 01, 2024

Dolby Laboratories, Inc., Annual General Meeting, Feb 06, 2024

Full year 2023 earnings released: EPS: US$2.10 (vs US$1.84 in FY 2022)

Dolby Laboratories, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2024

Dolby Laboratories, Inc. to Report Fiscal Year 2023 Results on Nov 16, 2023

Dolby Laboratories, Inc. Unveils New Dolby Atmos Innovation Coming to TCL TVS Ahead of IFA 2023

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2023

Third quarter 2023 earnings released: EPS: US$0.17 (vs US$0.40 in 3Q 2022)

Dolby Laboratories, Inc. to Report Q3, 2023 Results on Aug 03, 2023

Second quarter 2023 earnings released: EPS: US$1.00 (vs US$0.36 in 2Q 2022)

Dolby Laboratories, Inc. Announces Cash Dividend, Payable on May 23, 2023

Now 21% undervalued

Senior VP & Chief Marketing Officer recently sold €799k worth of stock

Independent Director recently sold €198k worth of stock

Independent Chairman recently sold €497k worth of stock

First quarter 2023 earnings released: EPS: US$0.83 (vs US$0.79 in 1Q 2022)

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on February 22, 2023

Dolby Laboratories, Inc. to Report Q1, 2023 Results on Feb 02, 2023

Dolby Laboratories, Inc., Annual General Meeting, Feb 07, 2023

Upcoming dividend of US$0.27 per share

Full year 2022 earnings released: EPS: US$1.84 (vs US$3.07 in FY 2021)

Dolby Laboratories, Inc. Provides Revenue Guidance for the Fiscal 2023

Dolby Laboratories, Inc. to Report Q4, 2022 Results on Nov 17, 2022

Upcoming dividend of US$0.25 per share

Third quarter 2022 earnings released: EPS: US$0.40 (vs US$0.54 in 3Q 2021)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2022

Dolby Laboratories, Inc. to Report Q3, 2022 Results on Aug 09, 2022

Insider recently sold €105k worth of stock

Second quarter 2022 earnings released: EPS: US$0.36 (vs US$0.75 in 2Q 2021)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2022 and Full Year Fiscal 2022

Dolby Laboratories, Inc. Announces Executive Changes

Dolby Laboratories, Inc. to Report Q2, 2022 Results on May 05, 2022

Dolby Laboratories, Inc. Announces General Availability of Dolby.io Transcode API

Upcoming dividend of US$0.25 per share

Dolby Laboratories, Inc. (NYSE:DLB) acquired Millicast, Inc. for $39 million.

Dolby Announces A Cash Dividend Payable on February 23, 2022

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: EPS US$3.07 (vs US$2.30 in FY 2020)

Insider recently sold €145k worth of stock

Senior VP & Chief Marketing Officer recently sold €232k worth of stock

Upcoming dividend of US$0.22 per share

Third quarter 2021 earnings released: EPS US$0.54 (vs US$0.67 in 3Q 2020)

Dolby Laboratories, Inc.(NYSE:DLB) dropped from Russell 3000 Growth Index

Dolby Laboratories Reaffirms Revenue Guidance for the Year 2021

Second quarter 2021 earnings released: EPS US$0.75 (vs US$0.88 in 2Q 2020)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Third Quarter and Second Half of 2021

New 90-day high: €81.50

Dolby Laboratories, Inc. Appoints Emily Rollins to the Board

Senior VP & Chief Marketing Officer recently sold €179k worth of stock